Search Results 941-950 of 17876 for Assay

1. A Study Of Belantamab Mafodotin Administered In Combination With Lenalidomide And Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, And Dexamethasone (DRd) In Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible For Autologous Stem Cell Transplantation (TI-NDMM) - Mayo Clinic

   Serum free light-chain (FLC) assay: involved FLC level ≥10 mg/dL (≥100 mg/L) and an abnormal serum FLC ratio (\<0.26 or \>1.65). 5. Newly diagnosed and ...

2. INCB161734 For Advanced Or Metastatic Solid Tumors With KRAS G12D Mutation - Mayo Clinic

   ... assay having a relevant mark of conformity for analytical performance (eg, CLIA [US] or UKCA, CE, CE UKNI, or others) to be eligible. Disease progression on ...

3. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

   - Serum free light chain (FLC) assay: Involved FLC level >= 10 mg/dL (>= 100 mg/L) and an abnormal serum free light chain ratio (< 0.26 or > 1.65) - Note ...

4. Hypothyroidism (underactive thyroid) - Diagnosis and treatment - Mayo Clinic

   The first blood test typically done to diagnose hypothyroidism measures the level of thyroid-stimulating hormone (TSH) in the blood. If it's high, the test is ...

5. Thyroid Cancer Clinical Trials - Mayo Clinic Research

   5) are safe for people with specific delta-like protein 3-expressing cancers. cfDNA Assay ... assays to detect cancer early in blood. The purpose of this ...

6. A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer - Mayo Clinic

   Note: If the participants' PD-L1 expression has already been assessed using same assay, testing platform, and scoring manual as part of the screening ...

7. Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD) - Mayo Clinic

   ... assay score (Oncotype RS>25, high risk Mammaprint, PAM-50, EndoPredict or ProSigna score). - Note: Eligibility requires primary tumor size ≥1.0 cm in ...

8. Mayo Clinic expert answers questions about COVID-19 testing

   I think the prudent thing to do would be to contact your physician and determine what assays they have available. Related posts: "Mayo Clinic Laboratories ...

9. Living-Donor Transplant Clinical Trials - Mayo Clinic Research

   The purpose of this study is to validate the use of an RNA-seq based peripheral blood assay in renal transplant recipients in adult kidney transplant recipients ...

10. Prerequisites and Requirements - M.D. Program - Mayo Clinic Alix School of Medicine

    The preferred method of testing is by Interferon-Gamma Release Assay (IGRA). This lab must be drawn within three months prior to program start ...